BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 17241619)

  • 1. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.
    Guillouzo A; Corlu A; Aninat C; Glaise D; Morel F; Guguen-Guillouzo C
    Chem Biol Interact; 2007 May; 168(1):66-73. PubMed ID: 17241619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Drug Metabolism by the Interplay of Inflammatory Signaling, Steatosis, and Xeno-Sensing Receptors in HepaRG Cells.
    Tanner N; Kubik L; Luckert C; Thomas M; Hofmann U; Zanger UM; Böhmert L; Lampen A; Braeuning A
    Drug Metab Dispos; 2018 Apr; 46(4):326-335. PubMed ID: 29330220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Analysis and Functional Characterization of HC-AFW1 Hepatocarcinoma Cells: Cytochrome P450 Expression and Induction by Nuclear Receptor Agonists.
    Braeuning A; Thomas M; Hofmann U; Vetter S; Zeller E; Petzuch B; Johänning J; Schroth W; Weiss TS; Zanger UM; Schwarz M
    Drug Metab Dispos; 2015 Nov; 43(11):1781-7. PubMed ID: 26310804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications.
    Nelson LJ; Morgan K; Treskes P; Samuel K; Henderson CJ; LeBled C; Homer N; Grant MH; Hayes PC; Plevris JN
    Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):30-37. PubMed ID: 27285124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creation and Preliminary Characterization of Pregnane X Receptor and Constitutive Androstane Receptor Knockout Rats.
    Forbes KP; Kouranova E; Tinker D; Janowski K; Cortner D; McCoy A; Cui X
    Drug Metab Dispos; 2017 Oct; 45(10):1068-1076. PubMed ID: 28716828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable Overexpression of the Constitutive Androstane Receptor Reduces the Requirement for Culture with Dimethyl Sulfoxide for High Drug Metabolism in HepaRG Cells.
    van der Mark VA; Rudi de Waart D; Shevchenko V; Elferink RP; Chamuleau RA; Hoekstra R
    Drug Metab Dispos; 2017 Jan; 45(1):56-67. PubMed ID: 27780834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical differences in drug metabolic properties of human hepatic cellular models, including primary human hepatocytes, stem cell derived hepatocytes, and hepatoma cell lines.
    Kvist AJ; Kanebratt KP; Walentinsson A; Palmgren H; O'Hara M; Björkbom A; Andersson LC; Ahlqvist M; Andersson TB
    Biochem Pharmacol; 2018 Sep; 155():124-140. PubMed ID: 29953844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Modifications of the Liver Tumor Cell Line HepG2 Increase Their Drug Metabolic Capacity.
    Ruoß M; Damm G; Vosough M; Ehret L; Grom-Baumgarten C; Petkov M; Naddalin S; Ladurner R; Seehofer D; Nussler A; Sajadian S
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies.
    Schulz C; Kammerer S; Küpper JH
    Clin Hemorheol Microcirc; 2019; 73(1):249-260. PubMed ID: 31561354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-species analysis of hepatic cytochrome P450 and transport protein expression.
    Hammer H; Schmidt F; Marx-Stoelting P; Pötz O; Braeuning A
    Arch Toxicol; 2021 Jan; 95(1):117-133. PubMed ID: 33150952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of 3D culture methods on human HepG2 cells.
    Luckert C; Schulz C; Lehmann N; Thomas M; Hofmann U; Hammad S; Hengstler JG; Braeuning A; Lampen A; Hessel S
    Arch Toxicol; 2017 Jan; 91(1):393-406. PubMed ID: 26872951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures.
    Yokoyama Y; Sasaki Y; Terasaki N; Kawataki T; Takekawa K; Iwase Y; Shimizu T; Sanoh S; Ohta S
    Biol Pharm Bull; 2018 May; 41(5):722-732. PubMed ID: 29445054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional polarization of human hepatoma HepaRG cells in response to forskolin.
    Mayati A; Moreau A; Le Vée M; Bruyère A; Jouan E; Denizot C; Parmentier Y; Fardel O
    Sci Rep; 2018 Oct; 8(1):16115. PubMed ID: 30382126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Nuclear Receptors PXR and CAR in Xenobiotic-Induced Hepatocyte Proliferation and Chemical Carcinogenesis.
    Yoshinari K
    Biol Pharm Bull; 2019; 42(8):1243-1252. PubMed ID: 31366862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450-dependent drug oxidation activities in commercially available hepatocytes derived from human induced pluripotent stem cells cultured for 3 weeks.
    Murayama N; Yamazaki H
    J Toxicol Sci; 2018; 43(4):241-245. PubMed ID: 29618712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the constitutive androstane receptor and shaken 3D-culturing increase biotransformation and oxidative phosphorylation and sensitivity to mitochondrial amiodarone toxicity of HepaRG cells.
    van der Mark VA; Adam AAA; Chang JC; Oude Elferink RP; Chamuleau RAFM; Hoekstra R
    Toxicol Appl Pharmacol; 2020 Jul; 399():115055. PubMed ID: 32428594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma: Gene expression profiling and regulation of xenobiotic-metabolizing cytochromes P450.
    Nekvindova J; Mrkvicova A; Zubanova V; Hyrslova Vaculova A; Anzenbacher P; Soucek P; Radova L; Slaby O; Kiss I; Vondracek J; Spicakova A; Bohovicova L; Fabian P; Kala Z; Palicka V
    Biochem Pharmacol; 2020 Jul; 177():113912. PubMed ID: 32173367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 1A1/2, 2B6 and 3A4 HepaRG Cell-Based Biosensors to Monitor Hepatocyte Differentiation, Drug Metabolism and Toxicity.
    Vlach M; Quesnot N; Dubois-Pot-Schneider H; Ribault C; Verres Y; Petitjean K; Rauch C; Morel F; Robin MA; Corlu A; Loyer P
    Sensors (Basel); 2019 May; 19(10):. PubMed ID: 31096615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of HepaRG cells following growth in proliferative and differentiated culture conditions reveals distinct bioenergetic profiles.
    Young CKJ; Young MJ
    Cell Cycle; 2019 Feb; 18(4):476-499. PubMed ID: 30755072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Analysis of Long Noncoding RNA Expression in Human Hepatocyte Cell Lines and Liver.
    Burenina OY; Zatsepin TS; Kim EF; Metelin AV; Skvortsov DA; Rubtsova MP; Dontsova OA
    Dokl Biochem Biophys; 2020 Jul; 493(1):181-184. PubMed ID: 32894460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.